Clinical studies by Dr. Barghouthi and Dr. Bloxham indicate that Verteporfin, when used with FUE and FUT hair transplantation methods, shows promise in hair follicle regeneration and minimal scarring due to its ability to inhibit Yes-associated protein (YAP). Microneedling at depths of 3-3.5mm, combined with Verteporfin, could potentially reactivate dormant follicles, although the optimal dosage and application method are still under investigation. Concerns remain about the DHT sensitivity of regenerated follicles, highlighting the need for further research to optimize trauma levels and Verteporfin concentrations to achieve effective and scar-free hair regeneration.
Iron or vitamin deficiencies can lead to decreased hair diameter, not just androgenetic alopecia. Treatments discussed include Minoxidil, finasteride, and RU58841.
Hair cloning is discussed as a potential future solution for hair loss, but it's not expected to be available soon due to high costs and technical challenges. Current treatments like Minoxidil, finasteride, and RU58841 are not mentioned in this conversation.
GT20029 is a new hair loss treatment in Phase 3 trials in China, using PROTAC technology to target androgen receptors, potentially with fewer side effects than finasteride and minoxidil. VDPHL01, a second-generation minoxidil, is also mentioned as potentially more effective.
A user shared their daily hair loss treatment routine, which includes 1mg of oral finasteride, 1mg of oral minoxidil, 1ml of castor oil, biotin, collagen, multivitamins, zinc, magnesium, liver supplements, RU58841 every night, and ketoconazole shampoo twice a week. They also mentioned a healthy lifestyle and a past unsuccessful hair transplant, but have experienced hair regrowth and thickening since starting their current regimen.